Clinical, functional and health-related quality of life correlates of clinically significant symptoms of anxiety and depression in patients with systemic sclerosis: a cross-sectional survey

• Published in: PloS one Vol. 9; no. 2; p. e90484
• Main Authors: Nguyen, Christelle, Ranque, Brigitte, Baubet, Thierry, Bérezné, Alice, Mestre-Stanislas, Caroline, Rannou, François, Papelard, Agathe, Morell-Dubois, Sandrine, Revel, Michel, Moro, Marie-Rose, Guillevin, Loïc, Poiraudeau, Serge, Mouthon, Luc
• Format: Journal Article
• Language: English
• Published: United States Public Library of Science 28.02.2014; Public Library of Science (PLoS)
• Subjects: Activities of daily living; Aged; Anxiety; Anxiety - diagnosis; Anxiety - psychology; Anxiety Disorders - diagnosis; Anxiety Disorders - psychology; Care and treatment; Clinical significance; Cross-Sectional Studies; Depression - diagnosis; Depression - psychology; Depressive Disorder - diagnosis; Depressive Disorder - psychology; Disability Evaluation; Female; Health; Health Surveys - methods; Health Surveys - statistics & numerical data; Hospital patients; Hospitals; Humans; Life expectancy; Male; Medicine; Mental depression; Middle Aged; Multivariate Analysis; Patients; Prospective Studies; Psychiatry; Quality of life; Quality of Life - psychology; Scleroderma; Scleroderma (Disease); Scleroderma, Systemic - diagnosis; Scleroderma, Systemic - psychology; Self image; Skin; Studies; Surveys; Surveys and Questionnaires; Systemic sclerosis; France
• ISSN: 1932-6203; 1932-6203
• DOI: 10.1371/journal.pone.0090484

To identify clinical, functional and health-related quality of life (HRQoL) correlates of clinically significant symptoms of anxiety and depression in patients with systemic sclerosis (SSc). Three-hundred-and-eighty-one patients fulfilling the American College of Rheumatology and/or the Leroy and Medsger criteria for SSc were assessed for visceral involvement, disability and HRQoL (assessed by SF-36). Clinically significant symptoms of anxiety and depression were evaluated with the Hospital Anxiety Depression Scale (HAD) (defined cut-off≥8). 9.2% the patients had limited SSc, 50.5% limited cutaneous SSc (lcSSc), and 40.3% diffuse cutaneous SSc (dcSSc). Overall, 40.4% and 58.8% of the patients had clinically significant symptoms of depression and anxiety, respectively. Compared to patients without clinically significant symptoms of depression, patients with clinically significant symptoms of depression had poorer health status, HRQoL mental and physical component, and greater global disability, hand disability and aesthetic impairment. Compared to patients without clinically significant symptoms of anxiety, patients with clinically significant symptoms of anxiety had poorer SF-36 mental and physical component scores. On multivariable analysis, excluding mental component score of SF-36, variables independently associated with clinically significant symptoms of depression and anxiety were global disability and physical component of SF-36, plus female gender for clinically significant symptoms of anxiety only. Remarkably, patients with and without clinically significant psychiatric symptoms were comparable for all disease-related clinical features assessed. High levels of clinically significant symptoms of anxiety and depression are observed among SSc patients. Clinically significant psychiatric symptoms are rather associated with increased disability and altered HRQoL, than with disease-specific organ manifestations.